MediWound to Report Third Quarter 2024 Financial Results
MediWound announced it will release its third quarter 2024 financial results on November 26, 2024. The results will cover the period ending September 30, 2024. Following the release, the company's management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide corporate updates. The call can be accessed using the following numbers: Toll-Free: 1-833-630-1956, Israel: 1-80-921-2373, International: 1-412-317-1837. A replay of the webcast will be available on the Investors section of the MediWound website.
MediWound ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il 26 novembre 2024. I risultati copriranno il periodo che termina il 30 settembre 2024. Dopo il rilascio, la direzione dell’azienda ospiterà una chiamata conferenza e un webcast dal vivo alle 8:30 a.m. Eastern Time per discutere dei risultati finanziari e fornire aggiornamenti aziendali. La chiamata sarà accessibile tramite i seguenti numeri: Numero verde: 1-833-630-1956, Israele: 1-80-921-2373, Internazionale: 1-412-317-1837. Una registrazione del webcast sarà disponibile nella sezione Investitori del sito web di MediWound.
MediWound anunció que publicará sus resultados financieros del tercer trimestre de 2024 el 26 de noviembre de 2024. Los resultados abarcarán el periodo que termina el 30 de septiembre de 2024. Tras la publicación, la dirección de la empresa llevará a cabo una llamada de conferencia y una retransmisión en vivo a las 8:30 a.m. Hora del Este para discutir los resultados financieros y proporcionar actualizaciones corporativas. La llamada se podrá acceder utilizando los siguientes números: Línea gratuita: 1-833-630-1956, Israel: 1-80-921-2373, Internacional: 1-412-317-1837. Una repetición de la retransmisión estará disponible en la sección de Inversionistas del sitio web de MediWound.
MediWound는 2024년 3분기 재무 결과를 2024년 11월 26일에 발표할 것이라고 발표했습니다. 이 결과는 2024년 9월 30일로 끝나는 기간을 다룹니다. 발표 후, 회사 경영진은 전화 회의 및 실시간 웹캐스트를 동부 표준시 기준 오전 8:30에 개최하여 재무 결과에 대해 논의하고 기업 업데이트를 제공할 것입니다. 회의에는 다음 번호를 사용하여 접속할 수 있습니다: 무료전화: 1-833-630-1956, 이스라엘: 1-80-921-2373, 국제전화: 1-412-317-1837. 웹캐스트의 재생은 MediWound 웹사이트의 투자자 섹션에서 볼 수 있습니다.
MediWound a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le 26 novembre 2024. Les résultats couvriront la période se terminant le 30 septembre 2024. Après la publication, la direction de l'entreprise animera une conférence téléphonique et un webinaire en direct à 8h30, heure de l'Est, pour discuter des résultats financiers et fournir des mises à jour sur l'entreprise. L'appel peut être accessible en utilisant les numéros suivants : Numéro sans frais: 1-833-630-1956, Israël: 1-80-921-2373, International: 1-412-317-1837. Un enregistrement du webinaire sera disponible dans la section des Investisseurs du site web de MediWound.
MediWound hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am 26. November 2024 veröffentlichen wird. Die Ergebnisse decken den Zeitraum bis zum 30. September 2024 ab. Nach der Veröffentlichung wird das Management des Unternehmens eine Konferenzschaltung und einen Live-Webcast um 8:30 Uhr Eastern Time veranstalten, um die Finanzergebnisse zu besprechen und Unternehmensaktualisierungen bereitzustellen. Die Teilnahme an dem Anruf ist unter den folgenden Nummern möglich: Gebührenfrei: 1-833-630-1956, Israel: 1-80-921-2373, International: 1-412-317-1837. Eine Aufzeichnung des Webcasts wird im Investorenbereich der MediWound-Website verfügbar sein.
- None.
- None.
Conference Call and Webcast Scheduled for Tuesday, November 26, 2024, at 8:30 a.m. Eastern Time
YAVNE, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the third quarter ended September 30, 2024, on Tuesday, November 26, 2024.
Following the release, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss these financial results and provide corporate updates.
Dial-in and call details are as follows:
| Conference Call & Webcast Details | |
| Toll-Free: | 1-833-630-1956 |
| Israel: | 1-80-921-2373 |
| International: | 1-412-317-1837 |
| Webcast: | Click HERE |
To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay on the Investors section of the MediWound website.
About MediWound
MediWound Ltd. (Nasdaq: MDWD) is a global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. The Company specializes in the development, production and commercialization of innovative biologics that enhance existing standards of care and improve patient experiences while reducing healthcare costs and unnecessary surgeries.
MediWound’s first drug, NexoBrid®, is an FDA- and EMA-approved orphan biologic for eschar removal in deep partial-thickness and/or full-thickness thermal burns, significantly reducing the need for surgical interventions. Leveraging its proprietary enzymatic technology, MediWound is advancing EscharEx®, a promising candidate currently in Phase III development for the debridement of chronic wounds. Phase II clinical trials have shown EscharEx has distinct advantages over the current
For more information visit www.mediwound.com and follow us on LinkedIn.
| MediWound Contacts: | |
| Hani Luxenburg | Daniel Ferry |
| Chief Financial Officer | Managing Director |
| MediWound Ltd. | LifeSci Advisors, LLC |
| ir@mediwound.com | daniel@lifesciadvisors.com |
| Media Contact: | |
| Ellie Hanson | |
| FINN Partners for MediWound | |
| ellie.hanson@finnpartners.com | |
| +1-929-588-2008 | |
FAQ
When will MediWound release its third quarter 2024 financial results?
What is the date and time of MediWound's Q3 2024 earnings call?
How can I access MediWound's Q3 2024 financial results conference call?
Will there be a replay available for MediWound's Q3 2024 earnings webcast?
